Cargando…
Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study
OBJECTIVES: To study the impact of blinding on estimated treatment effects, and their variation between trials; differentiating between blinding of patients, healthcare providers, and observers; detection bias and performance bias; and types of outcome (the MetaBLIND study). DESIGN: Meta-epidemiolog...
Autores principales: | Moustgaard, Helene, Clayton, Gemma L, Jones, Hayley E, Boutron, Isabelle, Jørgensen, Lars, Laursen, David R T, Olsen, Mette F, Paludan-Müller, Asger, Ravaud, Philippe, Savović, Jelena, Sterne, Jonathan A C, Higgins, Julian P T, Hróbjartsson, Asbjørn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190062/ https://www.ncbi.nlm.nih.gov/pubmed/31964641 http://dx.doi.org/10.1136/bmj.l6802 |
Ejemplares similares
-
Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
por: Jørgensen, Lars, et al.
Publicado: (2016) -
Mechanisms and direction of allocation bias in randomised clinical trials
por: Paludan-Müller, Asger, et al.
Publicado: (2016) -
Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies
por: Page, Matthew J., et al.
Publicado: (2016) -
Randomized clinical trials with run-in periods: frequency, characteristics and reporting
por: Laursen, David Ruben Teindl, et al.
Publicado: (2019) -
Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments
por: Boutron, Isabelle, et al.
Publicado: (2007)